SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mueller Brian

(Last)

(First)

(Middle)

C/O BIOMARIN PHARMACEUTICAL INC.

105 DIGITAL DRIVE

(Street)

NOVATO

94949

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/02/2011

3. Issuer Name and Ticker or Trading Symbol
BIOMARIN PHARMACEUTICAL INC [ BMRN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Corporate Controller

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,112	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	07/06/2006⁽¹⁾	01/05/2016	Common Stock	15,000	$11.74	D
Stock Option (right to buy)	05/20/2007⁽²⁾	11/19/2016	Common Stock	10,000	$17.54	D
Stock Option (right to buy)	12/07/2007⁽³⁾	06/06/2017	Common Stock	9,500	$17.33	D
Stock Option (right to buy)	12/27/2007⁽⁴⁾	06/26/2017	Common Stock	1,000	$17.89	D
Stock Option (right to buy)	11/22/2008⁽⁵⁾	05/21/2018	Common Stock	11,000	$38.59	D
Stock Option (right to buy)	06/17/2009⁽⁶⁾	12/16/2018	Common Stock	3,500	$17.86	D
Stock Option (right to buy)	11/12/2009⁽⁷⁾	05/11/2019	Common Stock	25,000	$14.39	D
Stock Option (right to buy)	11/12/2010⁽⁸⁾	05/11/2020	Common Stock	22,700	$21.51	D

Explanation of Responses:

1. Original option grant vests 6/48ths on July 6, 2006 and 1/48th on the 6th of each month thereafter.

2. Original option grant vests 6/48ths on May 20, 2007 and 1/48th on the 20th of each month thereafter.

3. Original option grant vests 6/48ths on December 7, 2007 and 1/48th on the 7th of each month thereafter.

4. Original option grant vests 6/48ths on December 27, 2007 and 1/48th on the 27th of each month thereafter.

5. Original option grant vests 6/48ths on November 22, 2008 and 1/48th on the 22nd of each month thereafter.

6. Original option grant vests 6/48ths on June 17, 2009 and 1/48th on the 17th of each month thereafter.

7. Original option grant vests 6/48ths on November 12, 2009 and 1/48th on the 12th of each month thereafter.

8. Original option grant vests 6/48ths on November 12, 2010 and 1/48th on the 12th of each month thereafter.

Remarks:

	/s/Laura Randall Woodhead, Attorney-in-Fact	03/11/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.